US5907174016
US5907174016
Mesoblast Limited
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.86B EUR | 17.52B EUR | 0 EUR | 23.24B EUR |
Enterprise Value | 1.81B EUR | 17.6B EUR | -- | 23.25B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 31.41x | -- | -- | -- |
Price to Sales | 15.43x | -- | -- | -- |
Price to Book | 3.26x | 30.83x | -- | 40.45x |
EV/Revenue | 15.08x | -- | -- | -- |
EV/EBITDA | -40.65x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -2.8% | -0.25% | -- | -0.21% |